PubMed

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.

Diabetes Care. 2008 Apr;31(4):747-52. Epub 2007 Dec 27.PMID: 18162497 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.

Tarnow L, Hildebrandt P, Hansen BV, Borch-Johnsen K, Parving HH.

Diabetologia. 2005 Jan;48(1):149-55. Epub 2004 Dec 23.PMID: 15616804 [PubMed - indexed for MEDLINE]Related articles

Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy.

Päivä H, Lehtimäki T, Laakso J, Ruokonen I, Rantalaiho V, Wirta O, Pasternack A, Laaksonen R.

Metabolism. 2003 Mar;52(3):303-7.PMID: 12647267 [PubMed - indexed for MEDLINE]Related articles

Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes.

Hanai K, Babazono T, Nyumura I, Toya K, Tanaka N, Tanaka M, Ishii A, Iwamoto Y.

Nephrol Dial Transplant. 2009 Jun;24(6):1884-8. Epub 2009 Jan 7.PMID: 19131352 [PubMed - indexed for MEDLINE]Related articles

Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.

Krzyzanowska K, Mittermayer F, Shnawa N, Hofer M, Schnabler J, Etmüller Y, Kapiotis S, Wolzt M, Schernthaner G.

Diabet Med. 2007 Jan;24(1):81-6.PMID: 17227328 [PubMed - indexed for MEDLINE]Related articles

Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.

Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.

Diabetes Care. 1996 Dec;19(12):1382-7.PMID: 8941468 [PubMed - indexed for MEDLINE]Related articles

Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.

Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E, Fliser D.

J Am Soc Nephrol. 2002 Jan;13(1):170-6.PMID: 11752034 [PubMed - indexed for MEDLINE]Related articlesFree article

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.

Sibal L, Agarwal SC, Schwedhelm E, Lüneburg N, Böger RH, Home PD.

Cardiovasc Diabetol. 2009 Jun 1;8:27.PMID: 19486510 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.

Maas R, Dentz L, Schwedhelm E, Thoms W, Kuss O, Hiltmeyer N, Haddad M, Klöss T, Standl T, Böger RH.

Crit Care Med. 2007 Aug;35(8):1876-81.PMID: 17581491 [PubMed - indexed for MEDLINE]Related articles

Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Tarnow L, Astrup AS, Parving HH.

Scand J Clin Lab Invest Suppl. 2005;240:73-9.PMID: 16112962 [PubMed - indexed for MEDLINE]Related articles

Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.

Xiong Y, Lei M, Fu S, Fu Y.

Life Sci. 2005 May 27;77(2):149-59. Epub 2005 Feb 2.PMID: 15862600 [PubMed - indexed for MEDLINE]Related articles

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.

Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM.

Diabetologia. 2008 Nov;51(11):2100-7. Epub 2008 Aug 22.PMID: 18719882 [PubMed - indexed for MEDLINE]Related articles

Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.

Oğuz A, Uzunlulu M, Yorulmaz E, Yalçin Y, Hekim N, Fici F.

Anadolu Kardiyol Derg. 2007 Dec;7(4):383-7.PMID: 18065333 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

Hovind P, Tarnow L, Oestergaard PB, Parving HH.

Kidney Int Suppl. 2000 Apr;75:S56-61.PMID: 10828763 [PubMed - indexed for MEDLINE]Related articles

A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.

Yamagishi S, Ueda S, Okuda S.

Med Hypotheses. 2007;69(4):922-4. Epub 2007 Mar 21.PMID: 17368960 [PubMed - indexed for MEDLINE]Related articles

The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.

Agardh CD, Agardh E, Torffvit O.

Diabetes Res Clin Pract. 1997 Mar;35(2-3):113-21.PMID: 9179466 [PubMed - indexed for MEDLINE]Related articles

Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.

Chen J, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH.

Diabetes Care. 1996 Feb;19(2):130-4.PMID: 8718432 [PubMed - indexed for MEDLINE]Related articles

Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.

Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, Schernthaner G.

Atherosclerosis. 2006 Nov;189(1):236-40. Epub 2006 Jan 18.PMID: 16414052 [PubMed - indexed for MEDLINE]Related articles

Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.

Selcuk MT, Selcuk H, Temizhan A, Maden O, Ulupinar H, Baysal E, Ozeke O, Sasmaz A.

Coron Artery Dis. 2007 Nov;18(7):545-51.PMID: 17925608 [PubMed - indexed for MEDLINE]Related articles